Jeffrey Chodakewitz
CIK 1610876 · EVP GMDA, CMO · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$36.30M
Companies
7
Total Filings
65
Lifetime Open-Market Net
-$30.85M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACET | Director | 1,106 | $8.20 | $9.1K | $0 | 8 | 2026-06-23 |
| SDGR | Director | 25,388 | $15.29 | $388.2K | $0 | 7 | 2026-06-23 |
| PRAX | Director | 1,371 | $295.81 | $405.6K | $0 | 6 | 2026-06-12 |
| NCNA | Director | — | $1.29 | — | $0 | 1 | 2024-08-23 |
| Adicet Bio, Inc. (TORC) Delisted | Director | — | — | — | $0 | 3 | 2020-06-05 |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Director | — | — | — | $0 | 5 | 2019-06-11 |
| VRTX | EVP GMDA, CMO | 72,385 | $490.39 | $35.50M | -$30.85M | 35 | 2018-02-14 |
Recent Filings · Page 2 of 7
65 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-16 | ACET | Mixed | — | $0 | EDGAR |
| 2023-06-16 | SDGR | Grant (A) | +6,250 | $0 | EDGAR |
| 2023-06-14 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2023-06-02 | ACET | Grant (A) | +5,900 | $0 | EDGAR |
| 2022-06-16 | SDGR | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | ACET | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | PRAX | Grant (A) | — | $0 | EDGAR |
| 2021-06-21 | SDGR | Grant (A) | — | $0 | EDGAR |
| 2021-05-04 | ACET | Grant (A) | — | $0 | EDGAR |
| 2021-04-15 | PRAX | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.